87457505 - TITAN PHARMACEUTICALS

Information

• Trademark
• 87457505

• Source

• Serial Number

  87457505

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  May 19, 2017
  7 years ago

• Transaction Date

  September 09, 2024
  3 months ago

• Status Date

  September 09, 2024
  3 months ago

• Published for Opposition Date

  June 14, 2022
  2 years ago

• Location Date

  August 09, 2022
  2 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  FROMM, MARTHA

• Attorney Docket Number

  304146014002

  Attorney Name

  Muzamil Huq

  Law Office Assigned Location Code

  L60

• Owners

  • TITAN PHARMACEUTICALS, INC

Case File Statements

• GS0051: Pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
• DS0000: "PHARMACEUTICALS"

Case File Event Statements

• 8/21/2017 - 7 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/23/2017 - 7 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 5/25/2017 - 7 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/18/2017 - 7 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/21/2017 - 7 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/21/2017 - 7 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 11/1/2017 - 7 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/1/2017 - 7 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/1/2017 - 7 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/6/2017 - 7 years ago

  10 - SUSPENSION LETTER WRITTEN Type: CNSL

• 11/6/2017 - 7 years ago

  11 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 11/6/2017 - 7 years ago

  12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 5/30/2019 - 5 years ago

  17 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 3/28/2018 - 6 years ago

  13 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK

• 5/24/2018 - 6 years ago

  14 - ASSIGNED TO LIE Type: ALIE

• 5/24/2018 - 6 years ago

  15 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 11/29/2018 - 6 years ago

  16 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 12/9/2019 - 5 years ago

  18 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 6/20/2020 - 4 years ago

  19 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 1/29/2021 - 3 years ago

  20 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 2/6/2021 - 3 years ago

  21 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 9/13/2021 - 3 years ago

  22 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 9/17/2021 - 3 years ago

  23 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 5/11/2022 - 2 years ago

  24 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 5/12/2022 - 2 years ago

  25 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/25/2022 - 2 years ago

  26 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/14/2022 - 2 years ago

  27 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/19/2023 - a year ago

  30 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/14/2022 - 2 years ago

  28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/9/2022 - 2 years ago

  29 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 1/19/2023 - a year ago

  31 - SOU EXTENSION 1 FILED Type: EXT1

• 1/19/2023 - a year ago

  32 - SOU EXTENSION 1 GRANTED Type: EX1G

• 1/21/2023 - a year ago

  33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/17/2023 - a year ago

  35 - SOU EXTENSION 2 FILED Type: EXT2

• 7/17/2023 - a year ago

  36 - SOU EXTENSION 2 GRANTED Type: EX2G

• 7/19/2023 - a year ago

  37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/17/2023 - a year ago

  34 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 9/9/2024 - 3 months ago

  45 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 9/9/2024 - 3 months ago

  46 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 12/27/2023 - 11 months ago

  40 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 12/27/2023 - 11 months ago

  38 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 12/27/2023 - 11 months ago

  39 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 1/28/2024 - 10 months ago

  41 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/28/2024 - 10 months ago

  42 - SOU EXTENSION 3 FILED Type: EXT3

• 1/28/2024 - 10 months ago

  43 - SOU EXTENSION 3 GRANTED Type: EX3G

• 1/30/2024 - 10 months ago

  44 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA